CA2100777A1 - Pharmaceutical composition containing granisetron and dexamethasone - Google Patents

Pharmaceutical composition containing granisetron and dexamethasone

Info

Publication number
CA2100777A1
CA2100777A1 CA002100777A CA2100777A CA2100777A1 CA 2100777 A1 CA2100777 A1 CA 2100777A1 CA 002100777 A CA002100777 A CA 002100777A CA 2100777 A CA2100777 A CA 2100777A CA 2100777 A1 CA2100777 A1 CA 2100777A1
Authority
CA
Canada
Prior art keywords
dexamethasone
pharmaceutical composition
composition containing
granisetron
containing granisetron
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002100777A
Other languages
French (fr)
Other versions
CA2100777C (en
Inventor
Gareth John Sanger
Christopher Stuart Dott
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
Gareth John Sanger
Christopher Stuart Dott
Smithkline Beecham P.L.C.
F. Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gareth John Sanger, Christopher Stuart Dott, Smithkline Beecham P.L.C., F. Hoffmann-La Roche Ag filed Critical Gareth John Sanger
Publication of CA2100777A1 publication Critical patent/CA2100777A1/en
Application granted granted Critical
Publication of CA2100777C publication Critical patent/CA2100777C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/243Platinum; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Toxicology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A pharmaceutical product comprising granisetron and dexamethasone as a combined preparation far simultaneous, sepa-rate or sequential use in the treatment and/or prevention of nausea and vomiting.
CA002100777A 1991-01-19 1992-01-16 Pharmaceutical composition containing granisetron and dexamethasone Expired - Lifetime CA2100777C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9101221.1 1991-01-19
GB919101221A GB9101221D0 (en) 1991-01-19 1991-01-19 Pharmaceuticals
PCT/GB1992/000091 WO1992012716A1 (en) 1991-01-19 1992-01-16 Pharmaceutical composition containing granisetron and dexamethasone

Publications (2)

Publication Number Publication Date
CA2100777A1 true CA2100777A1 (en) 1992-07-20
CA2100777C CA2100777C (en) 2003-08-19

Family

ID=10688722

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002100777A Expired - Lifetime CA2100777C (en) 1991-01-19 1992-01-16 Pharmaceutical composition containing granisetron and dexamethasone

Country Status (12)

Country Link
EP (1) EP0567498A1 (en)
JP (1) JP3521143B2 (en)
KR (1) KR930702991A (en)
AU (1) AU658169B2 (en)
CA (1) CA2100777C (en)
GB (1) GB9101221D0 (en)
IE (1) IE920148A1 (en)
MX (1) MX9200214A (en)
NZ (1) NZ241337A (en)
PT (1) PT100033B (en)
WO (1) WO1992012716A1 (en)
ZA (1) ZA92343B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY164077A (en) * 1999-05-13 2017-11-30 Pharma Mar Sa Compositions and uses of et743 for treating cancer
US20060263421A1 (en) * 2005-05-18 2006-11-23 Abeille Pharmaceuticals Inc Transdermal Method and Patch for Nausea
WO2008103852A1 (en) * 2007-02-21 2008-08-28 Victory Pharma, Inc. Transdermal delivery of dexamethasone and promethazine
JP5537104B2 (en) * 2009-09-16 2014-07-02 テルモ株式会社 Antiemetic
KR101368587B1 (en) * 2010-12-27 2014-03-05 주식회사 삼양바이오팜 Composition for prevention of nausea or vomiting
CN103222977A (en) * 2013-05-22 2013-07-31 南京工业大学 Granisetron and dexamethasone compound percutaneous controlled release patch and preparation method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3650772T2 (en) * 1985-04-27 2003-04-03 Hoffmann La Roche Derivatives of indazole-3-carboxamide and -3-carboxylic acid
GB8805269D0 (en) * 1988-03-04 1988-04-07 Glaxo Group Ltd Medicaments

Also Published As

Publication number Publication date
IE920148A1 (en) 1992-07-29
EP0567498A1 (en) 1993-11-03
MX9200214A (en) 1992-08-01
KR930702991A (en) 1993-11-29
CA2100777C (en) 2003-08-19
WO1992012716A1 (en) 1992-08-06
JP3521143B2 (en) 2004-04-19
AU658169B2 (en) 1995-04-06
AU1164192A (en) 1992-08-27
JPH06507152A (en) 1994-08-11
ZA92343B (en) 1992-12-30
PT100033A (en) 1993-02-26
PT100033B (en) 1999-09-30
NZ241337A (en) 1994-07-26
GB9101221D0 (en) 1991-02-27

Similar Documents

Publication Publication Date Title
AU3441293A (en) Antimicrobial compositions, process for preparing the same and use
CA2166483A1 (en) New Pharmaceutical Formulation
IL108372A0 (en) 2,6-Diaminopurine derivatives, their preparation and pharmaceutical compositions containing them
IL101864A0 (en) Thiopyranopyrrole derivatives,their preparation and pharmaceutical compositions containing them
IL100229A0 (en) N,o-sulphated heparosans,their preparation and pharmaceutical compositions containing them
AU646942B2 (en) 3,4,N-trisubstituted-4,5-dihydro-1H-pyrazole-1-carboxamides and their use as insecticides
IL110037A0 (en) Arylacetamides, their preparation, compositions containing them and their use as fungicides
IL105348A0 (en) Azabicyclo derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
AU3573793A (en) 3-(1H-tetrazol-5-yl)-4H-pyrido(1,2-a)pyrimidine-4-ones pharmaceutical compositions containing the same and the preparation thereof
AU678208B2 (en) 5-acylamino-1,2,4-thiadiazoles, their preparation and pharmaceutical compositions containing them
IL103151A0 (en) Beta-carboline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
AU5650894A (en) Tachyquinine antagonists, their preparation and use in pharmaceutical formulations
IL102500A0 (en) 3-deoxy-mannosamine derivatives,their preparation and pharmaceutical compositions containing them
CA2100777A1 (en) Pharmaceutical composition containing granisetron and dexamethasone
CA2158354A1 (en) Use of granisetron for the treatment of post-operative nausea and vomiting
AU662651B2 (en) Sulfamoyltriazole derivative and bactericide containing the same as active ingredient
IL102116A0 (en) Hetaryloxy-beta-carboline derivatives,processes for the preparation thereof,and pharmaceutical compositions containing the same
AU4075693A (en) Novel dihydroxybenzylamine derivatives, their preparation and pharmaceutical compositions containing same
AU1219092A (en) Substituted 2', 3'-dideoxy-5-trifluoromethyluridines, processes for their preparation and their use in medicaments
IL102666A0 (en) Quinolin-2-yl-methoxybenzyl-hydroxyureas,their preparation and pharmaceutical compositions containing them
IL103926A0 (en) Quinolylmethoxyphenyl-acetamides,their preparation and pharmaceutical compositions containing them
IL91737A0 (en) 2,7-diamino-1,2,3,4-tetrahydro-naphthalenes,their preparation and pharmaceutical compositions containing them
IL111216A0 (en) Heteroarylpiperidines, their preparation and pharmaceutical compositions containing them
IL104525A0 (en) 4-cinnolinyl-and 4-naphthyridinyl-dihydropyridines,their preparation and pharmaceutical compositions containing them
IL104424A0 (en) Pyrrolylbenzodiazepinones,their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry